Headlines

approval

Gc5445f30d69d6ee1adb9484b841fdc908c9164c62f9d9c10f 1744877171075 1744877171273

Venus Remedies stock jumps over 14% to 8-week high on FDA approval for anti-mircrobial resistance therapy

Admin03 mins

Shares of Venus Remedies, one of the largest manufacturers of meropenem antibiotics and an emerging player in AMR drugs in India, popped up 14.3% in Thursday’s trading session, April 17, to reach an 8-week high of ₹356.65. This rally came after the company, in an exchange filing today, announced that its investigational product, VRP-034, has…

Read More
Cipla S GAdvair And GAbraxane Products Are Awaitin 1684146419132 1744870962995

Does US approval for key cancer drug make Cipla shares an attractive buy amid tariff concerns?

Admin08 mins

Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump’s tariffs are looming on the horizon? “One product approval by itself doesn’t suddenly make a company more attractive,” said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. “Earlier-than-expected approval for Abraxane is positive,…

Read More
Enable Notifications OK No thanks